Tampa, FL (PRWEB) December 06, 2013
Morgan & Morgan’s Complex Litigation Group is investigating potential claims on behalf of Florida consumers who purchased a personalized $99 DNA test kit sold by 23andMe, Inc.
On November 22, the FDA issued a warning letter to 23andMe, Inc., instructing the company to discontinue its marketing of the DNA test kit. According to the letter, products used to diagnose, mitigate or prevent disease require marketing clearance or approval from the FDA; however, 23andMe, Inc. has not obtained FDA clearance or approval for its product, the agency said.
According to the FDA, the company has also not provided any assurance that it has analytically or clinically validated the DNA kit for its intended uses. In its letter, the FDA expressed concern about the potential health consequences posed to users who might seek unnecessary medical treatment as a result of false positive or false negative assessments for certain genetic risks, such as breast and ovarian cancer.
Morgan & Morgan’s Complex Litigation Group wants to hear from Florida consumers who purchased a personalized DNA test kit from 23andMe, Inc. Those who purchased the DNA test kit can visit http://www.forthepeople.com/ and fill out the free case review form for more information.
The genetic testing company is currently facing a putative class action lawsuit in California over the product. (Casey v. 23andMe Inc., case number 3:13-cv-02847, in the U.S. District Court for the Southern District of California.)
About Morgan & Morgan
Morgan & Morgan is one of the largest exclusively plaintiffs’ law firms in the country with 15 offices throughout Florida, Georgia, Mississippi, Tennessee, and New York. The firm handles cases nationally involving personal injury, medical malpractice, consumer class action, and securities fraud, as well as complex litigation against drug and medical device manufacturers. Visit Morgan & Morgan online at http://www.forthepeople.com/ for a free case evaluation and information about your legal rights.